Evidence map›Paper›PMID 42792753›Full record

ArticleBiomedicines2026

Mitochondrial Damage in Hemoglobinopathies: The Role of Cell-Free mtDNA as a Potential Biomarker.

Sebnem Tekin Neijmann, Asuman Gedikbasi, Feyza Nur Tuncer, Sukru Anil Dogan, Suzin Tatonyan, Mehmet Cihan Balci, Bengi Bekmez, Volkan Karaman, Gulden Fatma Gokcay, Zeynep Karakaş

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebnem Tekin NeijmannDepartment of Interdisciplinary Rare Diseases, Institute of Health Sciences, Istanbul University, 34452 Istanbul, Türkiye.ORCID 0000-0002-5422-5067
Asuman GedikbasiDepartment of Pediatric Basic Sciences, Institute of Child Health, Istanbul University, 34452 Istanbul, Türkiye.ORCID 0000-0001-7121-6077
Feyza Nur TuncerDepartment of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34093 Istanbul, Türkiye.ORCID 0000-0001-8233-1839
Sukru Anil DoganLife Sciences & Biotechnology Institute, Bezmialem Vakif University, 34820 Istanbul, Türkiye.
Suzin TatonyanDepartment of Immunology, Institute of Health Sciences, Istanbul University, 34452 Istanbul, Türkiye.
Mehmet Cihan BalciDivision of Nutrition and Metabolism, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, 34452 Istanbul, Türkiye.ORCID 0000-0002-3384-8679
Bengi BekmezCenter for Life Sciences and Technologies, Department of Molecular Biology and Genetics, Bogazici University, 34342 Istanbul, Türkiye.
Volkan KaramanDepartment of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, 34452 Istanbul, Türkiye.ORCID 0000-0001-8777-3548
Gulden Fatma GokcayDivision of Nutrition and Metabolism, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, 34452 Istanbul, Türkiye.ORCID 0000-0003-3726-5726
Zeynep KarakaşDivision of Hematology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, 34452 Istanbul, Türkiye.

Funding

Istanbul University TSA-2022-39178
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell-free mitochondrial DNAhemoglobinopathiessickle cell diseaseβ-thalassemia

Identifiers

PMID42792753
PMCPMC13604636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.